reported in approximately 4060% of participants in higher-dose groups [1] Vomiting reported in approximately 2030% of participants at higher doses Diarrhoea Constipation Decreased appetite (which, whilst contributing to weight loss, can also be uncomfortable) The majority of gastrointestinal events were mild to moderate in severity and tended to diminish over time as participants adjusted to the medication
InjectCo Fort Worth has earned 4.8 stars across 101 verified Google reviews from patients across West Fort Worth, Benbrook, North Richland Hills, and surrounding communities
Glutamate, via conversion to -ketoglutarate, a key TCA cycle intermediate, serves an anaplerotic role in energy metabolism 73
A study of 6522 patients found that 24 (0.4%) had experienced adverse reactions, the most frequent being anorexia, nausea, vomiting, and rash [29]